Dr Michael Edelman
Chief Executive Officer
Nanoco technologies
Korea
Biography
Nanoco is led by Dr Michael Edelman who joined the Group twelve years ago in September 2004. Michael led the initial fundraising, spun Nanoco out of the University of Manchester, floated the Group on the London Stock Exchange in 2009 and grew Nanoco into the world-leading quantum dot player it is today. Prior to Nanoco, Michael held a number of executive roles, including having responsibility for licensing the technology developed by GE/Bayer joint venture, Exatec LLP, vice president and managing director at yet2. com, commercial director at Colloids Ltd and business manager at Brunner Mond & Co Ltd. Michael started his career with ICI, has a PhD in organometallic chemistry from the University of Sussex, UK, and an undergraduate degree in classics and chemistry from Tufts University, Boston, MA, USA.
Research Interest
Nanoco is led by Dr Michael Edelman who joined the Group twelve years ago in September 2004. Michael led the initial fundraising, spun Nanoco out of the University of Manchester, floated the Group on the London Stock Exchange in 2009 and grew Nanoco into the world-leading quantum dot player it is today. Prior to Nanoco, Michael held a number of executive roles, including having responsibility for licensing the technology developed by GE/Bayer joint venture, Exatec LLP, vice president and managing director at yet2. com, commercial director at Colloids Ltd and business manager at Brunner Mond & Co Ltd. Michael started his career with ICI, has a PhD in organometallic chemistry from the University of Sussex, UK, and an undergraduate degree in classics and chemistry from Tufts University, Boston, MA, USA.
